• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

CCL17 Gene Record

  • Summary
  • Interactions
  • Claims
  • CCL17 6361 Druggable Genome

    Alternate Names:

    6361
    C-C MOTIF CHEMOKINE LIGAND 17
    CCL17
    A-152E5.3
    ABCD-2
    SCYA17
    TARC
    601520
    10615
    ENSG00000102970
    OTTHUMG00000133468

    Gene Info:

    Gene Biotype PROTEIN_CODING
    (0 More Sources)

    Gene Categories: Category Details

    CELL SURFACE
    DRUGGABLE GENOME

    Publications:

    Toebak et al., 2008, Differential suppression of dendritic cell cytokine production by anti-inflammatory drugs., Br. J. Dermatol.
    Duftner et al., 2006, Preferential type 1 chemokine receptors and cytokine production of CD28- T cells in ankylosing spondylitis., Ann. Rheum. Dis.
    Belperio et al., 2004, The role of the Th2 CC chemokine ligand CCL17 in pulmonary fibrosis., J. Immunol.
    Furukawa et al., 2004, Enhanced TARC production by dust-mite allergens and its modulation by immunosuppressive drugs in PBMCs from patients with atopic dermatitis., J. Dermatol. Sci.
    Traidl-Hoffmann et al., 2006, Impact of desloratadine and loratadine on the crosstalk between human keratinocytes and leukocytes: Implications for anti-inflammatory activity of antihistamines., Int. Arch. Allergy Immunol.
  • LORATADINE   CCL17

    Interaction Score: 0.97

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    16741367


    Sources:
    NCI

  • BLEOMYCIN   CCL17

    Interaction Score: 0.81

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    15383605


    Sources:
    NCI

  • INFLIXIMAB   CCL17

    Interaction Score: 0.77

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    16219708


    Sources:
    NCI

  • DICLOFENAC   CCL17

    Interaction Score: 0.74

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    18028503


    Sources:
    NCI

  • TACROLIMUS   CCL17

    Interaction Score: 0.45

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    15194145


    Sources:
    NCI

  • HYDROCORTISONE   CCL17

    Interaction Score: 0.42

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    18028503


    Sources:
    NCI

  • CYCLOSPORINE   CCL17

    Interaction Score: 0.25

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    18028503


    Sources:
    NCI

  • DEXAMETHASONE   CCL17

    Interaction Score: 0.19

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    18028503


    Sources:
    NCI

  • Ensembl: ENSG00000102970

    • Version: 101_38

    Alternate Names:
    CCL17 Ensembl Gene Name

    Gene Info:
    Gene Biotype PROTEIN_CODING

    Publications:

  • NCI: CCL17

    • Version: 14-September-2017

    Alternate Names:

    Gene Info:

    Publications:
    Toebak et al., 2008, Differential suppression of dendritic cell cytokine production by anti-inflammatory drugs., Br. J. Dermatol.
    Bäumer et al., 2004, TARC and RANTES, but not CTACK, are induced in two models of allergic contact dermatitis. Effects of cilomilast and diflorasone diacetate on T-cell-attracting chemokines., Br. J. Dermatol.
    Schnyder-Candrian et al., 2006, Interleukin-17 is a negative regulator of established allergic asthma., J. Exp. Med.

  • HingoraniCasas: ENSG00000102970

    • Version: 31-May-2017

    Alternate Names:
    ENSG00000102970 Gene Symbol
    CCL17 Ensembl Id

    Gene Info:

    Gene Categories:
    DRUGGABLE GENOME

    Publications:

  • GO: CCL17

    • Version: 01-February-2022

    Alternate Names:
    SCYA17 GO Gene Synonym
    TARC GO Gene Synonym

    Gene Info:

    Gene Categories:
    CELL SURFACE

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21